The president has signed an executive order stating that the US will institute a “most-favored-nation” policy, whereby the US will pay the same price for a drug as the nation that pays the lowest ...

It's no secret that brand-name drugs in the U.S. are much more expensive than they are abroad. In the spirit of fairness, the ...

Lowering drug prices to European benchmarks would ultimately reduce innovation and cost American consumers just over half a ...

More than 100 days into President Donald Trump’s second term, the administration has fallen into a pattern. Trump releases an ...

Denmark’s economic growth, which was driven by what economists described as an “exceptional surge” in pharmaceutical exports, ...

President Donald Trump signed an Executive Order (EO) titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients” aimed ...

The emerging gender gap within Gen Z — the demographic cohort born between 1997 and 2012 — is central to understanding the ...

Congressional Democrats who praised former President Joe Biden’s executive actions against America’s pharmaceutical industry are holding their praise for President Trump’s latest executive order.

Toward the end of his first Administration, Trump signed a similar Executive Order aimed at lowering the prices of some drugs ...

Lawmakers seek answers to questions about sweeping cuts to federal public health infrastructure but Kennedy stays mum.

This is misleading. Prices for most prescription drugs — unbranded generics are the exception — are higher in the U.S. than ...